Page last updated: 2024-08-25

sofosbuvir and Hematologic Malignancies

sofosbuvir has been researched along with Hematologic Malignancies in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Huang, Y; Rao, A	1
Ebeid, FSE; El-Haddad, A; El-Sayed, MH; Elsayed, W; Gaggar, A; Kersey, K; Massetto, B; Zekri, AR; Zhang, F	1
Brancaccio, G; Cantone, M; Ceccherini-Silberstein, F; Fabeni, L; Frigeri, F; Gaeta, GB; Genderini, F; Perno, CF; Pinto, A; Rizzo, V; Sorbo, MC	1

Reviews

1 review(s) available for sofosbuvir and Hematologic Malignancies

Article	Year
Connections between TET proteins and aberrant DNA modification in cancer. Trends in genetics : TIG, 2014, Volume: 30, Issue:10 Topics: 5-Methylcytosine; Azacitidine; Cytosine; Decitabine; Dioxygenases; DNA Methylation; DNA Modification Methylases; DNA-Binding Proteins; Hematologic Neoplasms; Humans; Isocitrate Dehydrogenase; Mixed Function Oxygenases; Molecular Targeted Therapy; Mutation; Neoplasms; Proto-Oncogene Proteins; Small Molecule Libraries	2014

Article

Year

Connections between TET proteins and aberrant DNA modification in cancer.

Trends in genetics : TIG, 2014, Volume: 30, Issue:10

Topics: 5-Methylcytosine; Azacitidine; Cytosine; Decitabine; Dioxygenases; DNA Methylation; DNA Modification Methylases; DNA-Binding Proteins; Hematologic Neoplasms; Humans; Isocitrate Dehydrogenase; Mixed Function Oxygenases; Molecular Targeted Therapy; Mutation; Neoplasms; Proto-Oncogene Proteins; Small Molecule Libraries

2014

Trials

1 trial(s) available for sofosbuvir and Hematologic Malignancies

Article	Year
Ledipasvir-sofosbuvir in Adolescents With Chronic Hepatitis C and Hematological Malignancies Undergoing Chemotherapy. Journal of pediatric gastroenterology and nutrition, 2022, 05-01, Volume: 74, Issue:5 Topics: Adolescent; Antiviral Agents; Benzimidazoles; Child; Diarrhea; Drug Therapy, Combination; Female; Fluorenes; Genotype; Hematologic Neoplasms; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Sofosbuvir; Treatment Outcome	2022

Article

Year

Ledipasvir-sofosbuvir in Adolescents With Chronic Hepatitis C and Hematological Malignancies Undergoing Chemotherapy.

Journal of pediatric gastroenterology and nutrition, 2022, 05-01, Volume: 74, Issue:5

Topics: Adolescent; Antiviral Agents; Benzimidazoles; Child; Diarrhea; Drug Therapy, Combination; Female; Fluorenes; Genotype; Hematologic Neoplasms; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Sofosbuvir; Treatment Outcome

2022

Other Studies

1 other study(ies) available for sofosbuvir and Hematologic Malignancies

Article	Year
Treatment of Acute Hepatitis C With Ledipasvir and Sofosbuvir in Patients With Hematological Malignancies Allows Early Re-start of Chemotherapy. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2018, Volume: 16, Issue:6 Topics: Adult; Antineoplastic Agents; Antiviral Agents; Benzimidazoles; Drug Therapy; Female; Fluorenes; Hematologic Neoplasms; Hepatitis C; Humans; Male; Middle Aged; Sofosbuvir	2018

Article

Year

Treatment of Acute Hepatitis C With Ledipasvir and Sofosbuvir in Patients With Hematological Malignancies Allows Early Re-start of Chemotherapy.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2018, Volume: 16, Issue:6

Topics: Adult; Antineoplastic Agents; Antiviral Agents; Benzimidazoles; Drug Therapy; Female; Fluorenes; Hematologic Neoplasms; Hepatitis C; Humans; Male; Middle Aged; Sofosbuvir

2018